Literature DB >> 30647174

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.

Sabrina M Nielsen1,2, Peter Tugwell1,2, Maarten P T de Wit1,2, Maarten Boers1,2, Dorcas E Beaton1,2, Thasia G Woodworth1,2, Reuben Escorpizo1,2, Beverley Shea1,2, Karine Toupin-April1,2, Francis Guillemin1,2, Vibeke Strand1,2, Jasvinder A Singh1,2, Margreet Kloppenburg1,2, Daniel E Furst1,2, George A Wells1,2, Josef S Smolen1,2, Richard Veselý1,2, Annelies Boonen1,2, Helene Storgaard1,2, Marieke Voshaar1,2, Lyn March1,2, Robin Christensen3,4.   

Abstract

OBJECTIVE: The Contextual Factors Working Group aims to provide guidance on addressing contextual factors in rheumatology trials within OMERACT.
METHODS: During the Special Interest Group session at OMERACT 2018, preliminary results were presented from a case scenario survey and semistructured interviews, including contextual factors mentioned in these. A group-based exercise sought to identify and rank important generic contextual factors.
RESULTS: A total of 79 candidate factors were listed. Across the 3 groups, gender/sex, comorbidities, and the healthcare system were ranked as most important.
CONCLUSION: The identified important contextual factor domains may be considered a provisional list pending further research.

Keywords:  CLINICAL TRIALS; OMERACT; OUTCOMES; RHEUMATIC DISEASES

Year:  2019        PMID: 30647174     DOI: 10.3899/jrheum.181081

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Efficacy of platelet-rich plasma and plasma for symptomatic treatment of knee osteoarthritis: a double-blinded placebo-controlled randomized clinical trial.

Authors:  Murillo Dório; Rosa Maria Rodrigues Pereira; Alexandre Galeno Branco Luz; Leticia Alle Deveza; Ricardo Manoel de Oliveira; Ricardo Fuller
Journal:  BMC Musculoskelet Disord       Date:  2021-09-24       Impact factor: 2.362

2.  Prognostic factors for work disability in patients with chronic widespread pain and fibromyalgia: protocol for a cohort study.

Authors:  Pernille H Duhn; Henning Locht; Eva Ejlersen Wæhrens; Robin Christensen; Karsten Thielen; Marius Henriksen; Lars Erik Kristensen; Henning Bliddal; Kirstine Amris
Journal:  BMJ Open       Date:  2021-12-22       Impact factor: 2.692

3.  EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis.

Authors:  Annelies Boonen; Polina Putrik; Mary Lucy Marques; Alessia Alunno; Lydia Abasolo; Dorcas Beaton; Neil Betteridge; Mathilda Bjørk; Maarten Boers; Boryana Boteva; Bruno Fautrel; Francis Guillemin; Elsa F Mateus; Elena Nikiphorou; Márta Péntek; Fernando Pimentel Santos; Johannes L Severens; Suzanne M M Verstappen; Karen Walker-Bone; Johan Karlsson Wallman; Marieke M Ter Wee; René Westhovens; Sofia Ramiro
Journal:  Ann Rheum Dis       Date:  2021-04-08       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.